Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FJVJ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,369
Award facts
- Contract value 100% obligated
- $2,368.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $2,368.86 delivery order to DMS Pharmaceutical Group Inc. on May 28, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for XOLAIR 75 mg/0.5 ml syringes.
DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of June 18, 2026.
Quick answers
Who was awarded contract SPE2DR26FJVJ3?
SPE2DR26FJVJ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 28, 2026.
How much is contract SPE2DR26FJVJ3 worth?
The government has obligated $2,369 on SPE2DR26FJVJ3.
Is contract SPE2DR26FJVJ3 an order under another contract?
Yes. SPE2DR26FJVJ3 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJVJ3 competed?
The extent of competition for SPE2DR26FJVJ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award